Evolent Health (EVH) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Evolent Health (EVH) over the last 12 years, with Q3 2025 value amounting to -$20.9 million.
- Evolent Health's Income towards Parent Company rose 982.41% to -$20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.2 million, marking a year-over-year decrease of 22998.51%. This contributed to the annual value of -$463000.0 for FY2022, which is 9367.23% up from last year.
- Latest data reveals that Evolent Health reported Income towards Parent Company of -$20.9 million as of Q3 2025, which was up 982.41% from -$19.9 million recorded in Q2 2025.
- In the past 5 years, Evolent Health's Income towards Parent Company registered a high of $1.6 million during Q2 2024, and its lowest value of -$64.6 million during Q1 2025.
- In the last 5 years, Evolent Health's Income towards Parent Company had a median value of -$19.9 million in 2025 and averaged -$17.7 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 62188.68% in 2021, then crashed by 134667.92% in 2025.
- Quarter analysis of 5 years shows Evolent Health's Income towards Parent Company stood at -$8.7 million in 2021, then soared by 94.68% to -$463000.0 in 2022, then plummeted by 4213.39% to -$20.0 million in 2023, then fell by 14.22% to -$22.8 million in 2024, then grew by 8.53% to -$20.9 million in 2025.
- Its Income towards Parent Company stands at -$20.9 million for Q3 2025, versus -$19.9 million for Q2 2025 and -$64.6 million for Q1 2025.